Durham University spin-out Magnitude Biosciences has secured
funding worth nearly £1 million in the last year to accelerate
revolutionary research into the ageing process and other significant
medical advances. And all from minuscule worms created in a shed.
Here, chief executive Fozia Saleem tells Colin Young more about
the company’s growth blueprint, getting to grips with its scientific
complexities and how it is taking worms to the world.